Brain Inflammation, Cholesterol, and Glutamate as Interconnected Participants in the Pathology of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|6|719-738

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.6, 2006-02, pp. : 719-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesterol and Apoe: A Target for Alzheimer's Disease Therapeutics

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 553-567

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary Research Highlights: Untangling Alzheimer Disease Pathology

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 5, 2015-06 ,pp. : 562-563

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’’s disease and genetics of inflammation: a pharmacogenomic vision

By Vasto Sonya   Candore Giuseppina   Duro Giovanni   Lio Domenico   Grimaldi Maria Paola   Caruso Calogero  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1735-1745

Future Medicine

Access to resources Recommend Favorite

Platelets in Alzheimer's Disease-Associated Cellular Senescence and Inflammation

By  

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1727-1738

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Cell Signaling and Inflammation in Alzheimer's Disease

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 247-256

Bentham Science Publishers

Access to resources Recommend Favorite